Welcome to our dedicated page for Esquire Financial Holdings SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Esquire Financial Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Esquire Financial Holdings's regulatory disclosures and financial reporting.
Esquire Financial Holdings director Selig Zises reported net open-market sales of 30,000 shares of common stock. The transactions on March 18–19, 2026 were executed through indirect accounts, including a profit sharing plan and a trust, at prices around $105–$107 per share.
After these sales, reported indirect holdings include 6,501 shares in the profit sharing plan and 63,533 shares held by a trust, along with 15,716 shares held directly. Some reported holdings include restricted stock that will vest over future dates.
ESQ submitted a Form 144 notice through Fidelity Brokerage Services LLC on 03/19/2026 reporting proposed transactions in Common stock traded on NASDAQ. The notice lists stock awards dated 12/16/2025 (667 shares), 12/19/2025 (500 shares) and 01/05/2026 (1,141 shares).
Esquire Financial Holdings, Inc. filed its annual report outlining a niche, high-margin banking model focused on the litigation market and payment processing, alongside a planned acquisition. Through Esquire Bank, it serves law firms nationally and small businesses with tailored lending, escrow deposits and merchant acquiring services.
For 2025, Esquire highlights strong profitability with an average return on assets of 2.43%, return on equity of 19.41% and a 6.02% net interest margin, supported by a 48.6% efficiency ratio and fee income representing 17% of revenue. Low-cost core deposits totaled $2.06 billion with a 0.99% total deposit cost, anchored by litigation-related escrow and operating accounts that made up 78% of deposits, including $1.23 billion in longer-duration escrow or claimant trust balances.
The company emphasizes its litigation-related commercial loan portfolio of $1.18 billion, diversified real estate loans of $489.9 million, and a growing payment processing platform serving 93,000 merchants and processing $39.5 billion in 2025 card volume. Available liquidity of $1.12 billion, no outstanding borrowings and sizable unused FHLB and FRB capacities underpin balance sheet strength.
Esquire also discloses an Agreement and Plan of Merger with Signature Bancorporation, Inc. Under the terms, Signature shareholders will receive 2.63 shares of Esquire common stock per Signature share, implying a per-share value of $260.48 and an aggregate transaction value of approximately $348.4 million based on Esquire’s March 11, 2026 closing price. The exchange ratio can adjust between 2.50 and 2.80 based on the disposition value of approximately $70 million of specified Schedule A loans. The mergers, including the subsequent bank merger of Signature Bank into Esquire Bank, remain subject to shareholder and regulatory approvals and customary conditions.
Esquire Financial Holdings announces a proposed acquisition of Signature Bancorporation via a 100% stock transaction. The deal uses an exchange ratio of 2.63 Esquire shares per Signature share (range 2.50–2.80 tied to the treatment of four "Schedule A" loans), would give Signature shareholders ~28% of the combined company, and values Signature at about $260 per share (aggregate near $350 million).
Management projects the combination to be 23% accretive to 2027 EPS and 11% accretive to tangible book value at closing, creates a pro forma ~$4.8 billion asset franchise, and preserves the Signature brand as a division of Esquire; closing is subject to shareholder and regulatory approvals and currently expected in Q3 2026.
Esquire Financial Holdings entered into a merger agreement to combine with Signature Bancorporation. Under the agreement, Signature will first merge into a wholly owned Esquire subsidiary and then into Esquire, with Esquire as the ultimate surviving public company. Signature shareholders will receive an exchange ratio of 2.630 shares of Esquire Common Stock per share of Signature Common Stock, subject to adjustment between 2.50 and 2.80, and cash in lieu of fractional shares.
The agreement contemplates assumption and conversion of Signature equity awards, board expansions and specified executive roles at Esquire Bank, customary closing conditions including shareholder and regulatory approvals, effectiveness of a Form S-4 registration statement, and a $15.0 million termination fee payable by Signature in certain circumstances.
Esquire Financial Holdings agreed to acquire Signature Bancorporation in an all-stock merger that will create a combined bank with approximately $4.8 billion in assets at closing. Signature shareholders will receive 2.63 shares of Esquire common stock for each Signature share, with an exchange ratio that can adjust between 2.50 and 2.80 based on proceeds from the sale of about $70 million of specified Signature loans.
The deal is positioned as a strategic expansion into the Chicago market, reducing Esquire’s litigation vertical loan and funding concentrations from above 70% to below 50% and adding a long-standing commercial banking franchise. Esquire projects GAAP EPS accretion of 23% in 2027 and approximately 11% tangible book value accretion, with no capital raise.
Two Signature directors will join Esquire’s and Esquire Bank’s boards, and Signature’s top executives will lead the Chicago operations under the “Signature, a division of Esquire Bank” brand. Closing is subject to shareholder approvals, multiple banking regulatory approvals, effectiveness of a Form S-4, and other customary conditions. Signature may owe a $15.0 million termination fee if the merger agreement ends under specified circumstances.
Esquire Financial Holdings, Inc. announced that its Board of Directors approved a 14% increase in the regular quarterly dividend to $0.20 per share of common stock. The dividend is payable on March 2, 2026 to stockholders of record as of February 13, 2026. This higher payout reflects an updated capital return to shareholders while maintaining the company’s regular quarterly dividend framework.
Esquire Financial Holdings, Inc. reported that SVP & Chief Financial Officer Michael Lacapria received an award of 1,164 shares of common stock on January 29, 2026 at a price of $0, indicating a restricted stock grant.
These shares of restricted stock vest in three equal annual installments commencing on January 29, 2029. Following this award, Lacapria beneficially owns 17,606 shares of common stock directly and 3,250 shares indirectly through an IRA. He also holds several stock option positions, with certain grants fully vested and others vesting in three equal annual installments commencing on December 15, 2024.
Esquire Financial Holdings EVP and COO Eric S. Bader reported an award of 3,492 shares of common stock on January 29, 2026. The shares are restricted stock that vest in three equal annual installments beginning January 29, 2029.
After this grant, Bader beneficially owns 139,116 shares of common stock directly, which include multiple restricted stock awards with different vesting schedules from 2024 through 2028. He also indirectly holds 2,000 shares through an IRA.
Esquire Financial Holdings, Inc. executive Ari P. Kornhaber, EVP and Head of Corporate Development, reported an equity award of common stock. On January 29, 2026, he received 5,122 shares of restricted stock at a price of $0 per share, reflecting a compensatory grant.
These restricted shares vest in three equal annual installments beginning on January 29, 2029119,792 shares of common stock and indirectly owns 1,947 shares through an IRA.